Europe & Central Asia (excluding high income) vs North Korea: Cause of death, by non-communicable diseases, ages 60+, female

Europe & Central Asia (excluding high income)
76.8%
in 2021
North Korea
88.0%
in 2021
Europe & Central Asia (excluding high income) rank
17th
North Korea rank
14th

Cause of death, by non-communicable diseases, ages 60+, female over time

  • Europe & Central Asia (excluding high income)
  • North Korea
020406080100200020102021

How they compare

North Korea currently reports 88.0% against 76.8% in Europe & Central Asia (excluding high income), a difference of 11.2%.

That makes North Korea's figure about 1.1 times Europe & Central Asia (excluding high income)'s.

The two have swapped places 1 time across 6 shared years of data; in 2000 it was Europe & Central Asia (excluding high income) ahead.

Europe & Central Asia (excluding high income) ranks 17th and North Korea ranks 14th of 47 groups.

Across the 3 decades both report, Europe & Central Asia (excluding high income) averaged higher in 2 and North Korea in 1.

Head to head by decade

Decade Europe & Central Asia (excluding high income) North Korea Difference Ahead
2000s 97.2% 68.8% 28.4% Europe & Central Asia (excluding high income)
2010s 97.0% 89.9% 7.1% Europe & Central Asia (excluding high income)
2020s 81.6% 87.7% 6.1% North Korea

Averages of every year both report within each decade.

Frequently asked questions

Which has higher cause of death, by non-communicable diseases, ages 60+, female, Europe & Central Asia (excluding high income) or North Korea?
North Korea, at 88.0% against 76.8% in Europe & Central Asia (excluding high income) as of 2021.
What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Europe & Central Asia (excluding high income) and North Korea?
11.2%, with North Korea ahead.
How many years of comparable data are there for Europe & Central Asia (excluding high income) and North Korea?
6 years are reported by both, from 2000 to 2021.
How do Europe & Central Asia (excluding high income) and North Korea rank globally for cause of death, by non-communicable diseases, ages 60+, female?
Europe & Central Asia (excluding high income) ranks 17th and North Korea ranks 14th of 47 groups.
Where does this data come from?
Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe & Central Asia (excluding high income) vs North Korea: Cause of death, by non-communicable diseases, ages 60+, female. Statizoid, drawing on Global Health Estimates, World Health Organization (WHO). Retrieved 19 September 2026, from https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-60-female-percent-of-total-female-deaths/europe-and-central-asia-excluding-high-income/korea-dem-people-s-rep/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/cause-of-death-by-non-communicable-diseases-ages-60-female-percent-of-total-female-deaths/europe-and-central-asia-excluding-high-income/korea-dem-people-s-rep/">Europe & Central Asia (excluding high income) vs North Korea: Cause of death, by non-communicable diseases, ages 60+, female</a> — Statizoid

About this data

Indicator
Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+)
Unit
% of total female deaths ages 60+
Source
Global Health Estimates, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
232 places, 1,392 data points, 2000–2021
Last refreshed

Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.